SB 5020 - Rx drug price increases

Primary Sponsor: Karen Keiser

Status: By resolution, reintroduced and retained in present status. | leg.wa.gov summary

Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents.

Revisions


Created by @tannewt. Contribute on GitHub.